Skip to main content
. 2014 Jan;58(1):48–54. doi: 10.1128/AAC.02006-13

TABLE 1.

Pharmacokinetic parameters for predicted total and unbound terbinafine plasma concentrations on day 1, day 7, and day 28 for standard and high-dose terbinafine regimens

Parameter Day of therapy Values [total (unbound)] for indicated dose regimena
250 mg q24h 250 mg q12h 500 mg q24h 250 mg q8h 500 mg q12h
AUC0–24 (mg · h/liter) 1 5.40 (0.0540) 10.4 (0.104) 10.8 (0.108) 15.2 (0.152) 20.6 (0.206)
7 8.30 (0.0830) 16.4 (0.164) 16.6 (0.166) 24.6 (0.246) 32.9 (0.329)
28 9.73 (0.0973) 19.4 (0.194) 19.5 (0.195) 29.1 (0.291) 38.9 (0.389)
Cmax (mg/liter) 1 1.32 (0.0132) 1.35 (0.0135) 2.20 (0.0220) 1.39 (0.0139) 2.24 (0.0224)
7 1.46 (0.0146) 1.61 (0.0161) 2.46 (0.0246) 1.80 (0.0180) 2.78 (0.0278)
28 1.52 (0.0152) 1.74 (0.0174) 2.59 (0.0259) 1.99 (0.0199) 3.04 (0.0304)
Cmin (mg/liter) 1 0.0332 (0.000332) 0.0659 (0.000659) 0.0666 (0.000666) 0.162 (0.00162) 0.147 (0.00147)
7 0.143 (0.00143) 0.308 (0.00308) 0.288 (0.00288) 0.537 (0.00537) 0.632 (0.00632)
28 0.198 (0.00198) 0.427 (0.00427) 0.397 (0.00397) 0.722 (0.00722) 0.872 (0.00872)
a

For dose regimens where more than one dose is administered in a 24-h period, Cmax and Cmin values for each day of therapy represent the average of the Cmax and Cmin values for each dosing interval in the corresponding 24-h period.